Rafina Innovations Inc
Rafina Innovations Inc. engages in the research, development, commercialization, and marketing of medical technologies. It operates through two segments, Clinics and Technology. The company also operates prosthetics and orthotics, and diabetic foot total rehabilitation clinics in Southern Europe, the Middle East, and North Africa. In addition, it is involved in the research, development, and comm… Read more
Rafina Innovations Inc (VICA) - Net Assets
Latest net assets as of June 2022: $4.03 Million USD
Based on the latest financial reports, Rafina Innovations Inc (VICA) has net assets worth $4.03 Million USD as of June 2022.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($7.71 Million) and total liabilities ($3.68 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $4.03 Million |
| % of Total Assets | 52.32% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Rafina Innovations Inc - Net Assets Trend (2007–2021)
This chart illustrates how Rafina Innovations Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Rafina Innovations Inc (2007–2021)
The table below shows the annual net assets of Rafina Innovations Inc from 2007 to 2021.
| Year | Net Assets | Change |
|---|---|---|
| 2021-12-31 | $4.04 Million | +564.79% |
| 2020-12-31 | $-868.91K | +28.23% |
| 2019-12-31 | $-1.21 Million | -144.96% |
| 2018-12-31 | $-494.23K | +45.75% |
| 2017-12-31 | $-911.08K | +16.02% |
| 2016-12-31 | $-1.08 Million | +11.61% |
| 2015-12-31 | $-1.23 Million | -5944.33% |
| 2014-12-31 | $-20.30K | -256.79% |
| 2012-12-31 | $-5.69K | +97.04% |
| 2011-12-31 | $-192.06K | -13.87% |
| 2010-12-31 | $-168.67K | -26.54% |
| 2009-12-31 | $-133.29K | -32.04% |
| 2008-12-31 | $-100.95K | -70.66% |
| 2007-12-31 | $-59.15K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Rafina Innovations Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4192874000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2021)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $122.02K | 3.02% |
| Other Comprehensive Income | $-122.02K | -3.02% |
| Other Components | $46.07 Million | 1140.65% |
| Total Equity | $4.04 Million | 100.00% |
Rafina Innovations Inc Competitors by Market Cap
The table below lists competitors of Rafina Innovations Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
New Tech Venture S.A.
WAR:NTV
|
$440.65 |
|
Pakistan International Bulk Terminal Private Ltd
KAR:PIBTL
|
$440.71 |
|
British and American Investment Trust PLC
LSE:BAF
|
$441.06 |
|
Agavenny Corporation
PINK:AGNY
|
$441.50 |
|
Tesla Exploration Ltd
PINK:TXLZF
|
$439.26 |
|
The North American Income Trust plc
LSE:NAIT
|
$438.75 |
|
Terra Energy Res
PINK:TRRE
|
$438.45 |
|
Chrissworld Ltd
CM:CWLN0000
|
$437.96 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Rafina Innovations Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2020 to 2021, total equity changed from -868,912 to 4,038,603, a change of 4,907,515.
- Net loss of 879,207 reduced equity.
- Other comprehensive income decreased equity by 64,141.
- Other factors increased equity by 5,850,863.
Equity Change Factors (2020 to 2021)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-879.21K | -21.77% |
| Other Comprehensive Income | $-64.14K | -1.59% |
| Other Changes | $5.85 Million | +144.87% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Rafina Innovations Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2007-12-31 | $-0.06 | $0.00 | x |
| 2008-12-31 | $-0.08 | $0.00 | x |
| 2009-12-31 | $-0.11 | $0.00 | x |
| 2010-12-31 | $-0.14 | $0.00 | x |
| 2011-12-31 | $-0.15 | $0.00 | x |
| 2012-12-31 | $0.00 | $0.00 | x |
| 2013-12-31 | $-1.07 | $0.00 | x |
| 2014-12-31 | $-0.01 | $0.00 | x |
| 2015-12-31 | $-0.16 | $0.00 | x |
| 2016-12-31 | $-0.11 | $0.00 | x |
| 2017-12-31 | $-0.09 | $0.00 | x |
| 2018-12-31 | $-0.04 | $0.00 | x |
| 2019-12-31 | $-0.07 | $0.00 | x |
| 2020-12-31 | $-0.03 | $0.00 | x |
| 2021-12-31 | $0.05 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Rafina Innovations Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -21.77%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -26.95%
- • Asset Turnover: 0.42x
- • Equity Multiplier: 1.91x
- Recent ROE (-21.77%) is below the historical average (-1.45%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2007 | 0.00% | 0.00% | 0.00x | 0.00x | $-93.24K |
| 2008 | 0.00% | 0.00% | 0.00x | 0.00x | $-141.70K |
| 2009 | 0.00% | 0.00% | 0.00x | 0.00x | $-19.01K |
| 2010 | 0.00% | 0.00% | 0.00x | 0.00x | $-18.51K |
| 2011 | 0.00% | 0.00% | 0.00x | 0.00x | $-4.19K |
| 2012 | 0.00% | 0.00% | 0.00x | 0.00x | $-13.06K |
| 2013 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.21 Million |
| 2014 | 0.00% | -70275.52% | 0.05x | 0.00x | $-19.02 Million |
| 2015 | 0.00% | -15695.45% | 0.13x | 0.00x | $-9.31 Million |
| 2016 | 0.00% | -232.19% | 2.15x | 0.00x | $-1.49 Million |
| 2017 | 0.00% | -839.79% | 0.55x | 0.00x | $-2.90 Million |
| 2018 | 0.00% | -1417.52% | 1.38x | 0.00x | $-5.80 Million |
| 2019 | 0.00% | -2156.62% | 0.23x | 0.00x | $-1.08 Million |
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $1.91K |
| 2021 | -21.77% | -26.95% | 0.42x | 1.91x | $-1.28 Million |
Industry Comparison
This section compares Rafina Innovations Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Rafina Innovations Inc (VICA) | $4.03 Million | 0.00% | 0.91x | $440.50 |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |